FDA Needs More Aggressive Globalization Strategy – Sen. Brown
This article was originally published in The Tan Sheet
Executive Summary
The Ohio Democrat says FDA should be more creative in dealing with globalization problems than asking for funds to put more inspectors in China. Commissioner Hamburg says the agency is aggressive but lacks tools and resources to fully address globalization issues.
You may also be interested in...
FDA Flags Chinese Personal Care Products Maker For Drug GMP Failings
The agency will pursue cosmetics and personal care product companies as pharmaceutical manufacturers if their product labeling strays into drug territory. FDA’s warning letter to Shanghai Huhui Daily Use Chemical Products says its skin protectant cream does not comply with the OTC monograph.
FDA Flags Chinese Personal Care Products Maker For Drug GMP Failings
The agency will pursue cosmetics and personal care product companies as pharmaceutical manufacturers if their product labeling strays into drug territory. FDA’s warning letter to Shanghai Huhui Daily Use Chemical Products says its skin protectant cream does not comply with the OTC monograph.
Sequestration Could Drive An FDA Resources Review
FDA and advocates wait to see how an estimated 7.8% budget cut would be implemented, if enacted. Former agency officials say sequestration could lead to hiring freezes and program delays.